Antithrombotic Therapy after Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk. TAVR carries a risk for thrombotic and bleeding events, focusing on the importance of defining the opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousa, Tariq A. M., Mahfouz, Ahmed, Mohammed, Nazar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231539/
https://www.ncbi.nlm.nih.gov/pubmed/35757447
http://dx.doi.org/10.4103/heartviews.heartviews_36_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231539/
https://www.ncbi.nlm.nih.gov/pubmed/35757447
http://dx.doi.org/10.4103/heartviews.heartviews_36_22

Ejemplares similares